Pieris Pharmaceuticals Inc
CUSIP 720795103
Pieris Pharmaceuticals Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 14.0K shares worth $2,402 as of Q2 2024. The largest reported holders are Lynx1 Capital Management LP, Aquilo Capital Management, LLC, and Renaissance Technologies LLC.
Institutional Holders
1
Q2 2024
Reported Value
$2,402
Ticker
unmapped
private placement or foreign
Quarters Tracked
27
Ownership Trend
Institutional holders
Total reported value
Holders
··Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Lynx1 Capital Management LP$633M AUM | 0.41% | $2M | 8.78M | Q1 2024OLDER |
| Aquilo Capital Management, LLC$0 AUM | 0.89% | $984,351 | 3.30M | Q3 2023OLDER |
| RENAISSANCE TECHNOLOGIES LLC$63.9B AUM | 0.00% | $262,000 | 1.43M | Q1 2024OLDER |
| BlackRock Finance, Inc.$4.42T AUM | 0.00% | $190,096 | 1.04M | Q1 2024OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $177,234 | 967.4K | Q1 2024OLDER |
| ACADIAN ASSET MANAGEMENT LLC$70.5B AUM | 0.00% | $175,000 | 962.4K | Q1 2024OLDER |
| GEODE CAPITAL MANAGEMENT, LLC$1.61T AUM | 0.00% | $141,620 | 772.8K | Q1 2024OLDER |
| CM Management, LLC$120M AUM | 0.09% | $105,340 | 575.0K | Q1 2024OLDER |
| NORTHERN TRUST CORP$756.6B AUM | 0.00% | $44,626 | 243.6K | Q1 2024OLDER |
| PRUDENTIAL FINANCIAL INC$81.2B AUM | 0.00% | $40,451 | 220.8K | Q1 2024OLDER |
| MILLENNIUM MANAGEMENT LLC$240.3B AUM | 0.00% | $38,792 | 211.7K | Q1 2024OLDER |
| Squarepoint Ops LLC$85.1B AUM | 0.00% | $26,717 | 145.8K | Q1 2024OLDER |
| Summit Trail Advisors, LLC$7.0B AUM | 0.00% | $25,648 | 140.0K | Q1 2024OLDER |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM | 0.00% | $18,741 | 103.0K | Q4 2023OLDER |
| Virtu Financial LLC$2.4B AUM | 0.00% | $16,000 | 90.1K | Q4 2023OLDER |
| TWO SIGMA SECURITIES, LLC$861M AUM | 0.00% | $10,674 | 58.3K | Q1 2024OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $9,515 | 52.0K | Q1 2024OLDER |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $7,822 | 42.7K | Q1 2024OLDER |
| TWO SIGMA INVESTMENTS, LP$123.9B AUM | 0.00% | $7,446 | 40.9K | Q4 2023OLDER |
| Bank of New York Mellon Corp$543.9B AUM | 0.00% | $7,271 | 39.9K | Q4 2023OLDER |
| NorthStar Asset Management LLC /NJ/$207M AUM | 0.01% | $7,110 | 39.1K | Q4 2023OLDER |
| TWO SIGMA ADVISERS, LP$0 AUM | 0.00% | $6,210 | 33.9K | Q1 2024OLDER |
| RAYMOND JAMES & ASSOCIATES$164.1B AUM | 0.00% | $5,496 | 30.0K | Q1 2024OLDER |
| NJ State Employees Deferred Compensation Plan$0 AUM | 0.00% | $5,496 | 30.0K | Q1 2024OLDER |
| B. Riley Wealth Advisors, Inc.$1.6B AUM | 0.00% | $5,066 | 17.0K | Q1 2024OLDER |
| HRT FINANCIAL LP$40.1B AUM | 0.00% | $5,000 | 18.4K | Q3 2023OLDER |
| GROUP ONE TRADING LLC$52.2B AUM | 0.00% | $4,708 | 25.7K | Q1 2024OLDER |
| XTX Topco Ltd$5.8B AUM | 0.00% | $3,802 | 20.8K | Q1 2024OLDER |
| COMMERCE BANK$20.7B AUM | 0.00% | $3,664 | 20.0K | Q1 2024OLDER |
| WEALTH EFFECTS LLC$282M AUM | 0.00% | $3,487 | 11.7K | Q3 2023OLDER |
| Kestra Advisory Services, LLC$26.4B AUM | 0.00% | $3,206 | 17.5K | Q1 2024OLDER |
| Baader Bank Aktiengesellschaft$1.3B AUM | 0.00% | $2,742 | 20.3K | Q4 2023OLDER |
| Orange Investment Advisors, Inc.$772M AUM | 0.00% | $2,402 | 14.0K | Q2 2024 |
| Cerity Partners LLC$70.8B AUM | 0.00% | $1,886 | 10.3K | Q1 2024OLDER |
| US BANCORP \DE\$82.4B AUM | 0.00% | $1,883 | 10.3K | Q1 2024OLDER |
| Cutler Group LLC / CA$307M AUM | 0.00% | $1,000 | 4.5K | Q3 2023OLDER |
| BARCLAYS PLC$416.3B AUM | 0.00% | $917 | 5.0K | Q1 2024OLDER |
| RHUMBLINE ADVISERS$116.9B AUM | 0.00% | $339 | 1.9K | Q4 2023OLDER |
| Truvestments Capital LLC$554M AUM | 0.00% | $205 | 1.1K | Q1 2024OLDER |
| OSAIC HOLDINGS, INC.$68.3B AUM | 0.00% | $95 | 516 | Q1 2024OLDER |
| Allworth Financial LP$24.7B AUM | 0.00% | $65 | 350 | Q1 2024OLDER |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM | — | $0 | 0 | Q1 2024OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.